Overview

A HIDA (Hepatobiliary Iminodiacetic Acid) scan, also known as cholescintigraphy, is a nuclear medicine procedure used to evaluate the function and anatomy of the biliary system. This test uses a small amount of radioactive tracer that's taken up by the liver and excreted into bile, allowing physicians to visualize the flow of bile through the liver, bile ducts, gallbladder, and into the small intestine.

The HIDA scan is particularly valuable for diagnosing acute and chronic cholecystitis, assessing gallbladder ejection fraction, and detecting bile duct obstructions. It provides functional information that complements anatomical imaging like ultrasound or CT, making it an essential tool in evaluating patients with suspected biliary disease.

Common Procedures & Indications

Primary Indications

• Suspected Acute Cholecystitis: Most common indication for HIDA scanning
• Biliary Obstruction: Detecting blockages in the common bile duct
• Biliary Leak: Identifying leaks after surgery or trauma
• Gallbladder Dysfunction: Assessing ejection fraction in chronic acalculous cholecystitis
• Post-Cholecystectomy Symptoms: Evaluating persistent pain or suspected bile duct injury
• Sphincter of Oddi Dysfunction: Evaluating pancreaticobiliary sphincter function

Clinical Scenarios

• Right Upper Quadrant Pain: When ultrasound is inconclusive
• Elevated Liver Enzymes: Particularly alkaline phosphatase
• Fever and Jaundice: Suspected cholangitis or obstruction
• Post-Liver Transplant: Assessing biliary anastomosis patency
• Pediatric Biliary Disease: Evaluating biliary atresia or neonatal jaundice

Key Statistics

• Sensitivity for Acute Cholecystitis: 95-98%
• Specificity for Acute Cholecystitis: 90-95%
• Procedure Time: 60-90 minutes (can extend up to 2 hours with delayed imaging)
• Radiation Exposure: 3-6 mSv (equivalent to 10-20 chest X-rays)
• Accuracy for Biliary Obstruction: 85-90%
• Gallbladder Ejection Fraction Normal Range: 35-75%
• Cost: Approximately $500-1000 for the procedure

Patient Preparation Guide

Before Your Examination

• Fasting: Nothing by mouth for at least 4-6 hours before the test
• Medications: Hold opioid analgesics for 24 hours (can alter gallbladder function)
• Recent Contrast: Avoid CT or IV contrast within 24-48 hours if possible
• Pregnancy: Must be confirmed or ruled out before the procedure
• Nursing Mothers: Discontinue breastfeeding for 24-48 hours post-procedure
• Clothing: Comfortable clothing without metal zippers or buttons

During the Procedure

• Injection: A small amount of radioactive tracer is injected into a vein
• Imaging: You'll lie under a gamma camera as images are taken
• Duration: Initial images take 60 minutes, additional views may be needed
• Morphine Challenge: If gallbladder not visualized, morphine may be given to stimulate contraction
• Fatty Meal: May be given to assess gallbladder ejection fraction

After Your Examination

• Hydration: Drink plenty of fluids to help clear the radiopharmaceutical
• Radiation: The radioactive material is eliminated naturally from your body
• Breastfeeding: Can resume after 24-48 hours
• Activity: Resume normal activities immediately
• Results: Typically available within 24-48 hours
• Follow-up: Your doctor will discuss results and treatment options

The HIDA Scan Process

Normal Flow Pattern

1. Uptake: Radiotracer taken up by hepatocytes within minutes
2. Excretion: Tracer excreted into bile canals and ducts
3. Visualization: Common hepatic and common bile ducts appear within 5-10 minutes
4. Gallbladder Filling: Gallbladder visualized within 15-30 minutes
5. Intestinal Excretion: Tracer enters duodenum and small intestine

Abnormal Findings

• Non-visualization of Gallbladder: With gallbladder filling suggests acute cholecystitis
• Delayed Visualization: May indicate cystic duct obstruction
• Ductal Dilatation: Suggests obstruction below the level of visualization
• Biliary Leak: Extravasation of tracer outside the biliary tree
• Poor Hepatic Uptake: Indicates severe liver dysfunction

Pharmacologic Interventions

Sincalide (Cholecystokinin Analog)

• Purpose: To assess gallbladder ejection fraction
• Dosage: 0.02 mcg/kg infused over 30-60 minutes
• Normal Response: Gallbladder contracts and ejects 35-75% of contents
• Indication: For suspected chronic acalculous cholecystitis

Morphine Challenge

• Purpose: To contract sphincter of Oddi and improve gallbladder visualization
• Dosage: 0.04 mg/kg IV
• Effect: Gallbladder should visualize within 5-10 minutes
• Use: When initial scan fails to show gallbladder filling

Advantages

• High sensitivity for acute cholecystitis
• Provides functional assessment beyond anatomy
• Can evaluate gallbladder ejection fraction
• Detects biliary leaks and obstructions
• Useful in post-cholecystectomy patients
• Noninvasive compared to ERCP
• No sedation required
• Complementary to ultrasound findings

Limitations

• Cannot differentiate acute from chronic cholecystitis on imaging alone
• Limited in evaluating pancreatic duct pathology
• Reduced sensitivity in critically ill patients
• Cannot characterize gallstones (ultrasound better for this)
• Results may be affected by recent meals or medications
• Less available in some rural areas
• Radiation exposure (though small)

Related Modalities

• Ultrasound: First-line test for gallstones and gallbladder inflammation
• CT: Excellent for complications like perforation or abscess
• MRI/MRCP: Excellent for evaluating bile duct anatomy without radiation
• ERCP: Therapeutic option for stones and strictures with higher risk
• Endoscopic Ultrasound: High-resolution evaluation of biliary tree

Medical Disclaimer

Important Notice: This information is for educational purposes only and is not a substitute for professional medical advice. A HIDA scan involves exposure to small amounts of radiation. While the procedure is safe for most patients, pregnant women or those who might be pregnant should discuss risks with their healthcare provider.

The radioactive tracer used in this procedure has a short half-life and is eliminated from your body naturally within 24-48 hours. Allergic reactions to the tracer are extremely rare, though nausea can occasionally occur at the time of injection.

Individual results may vary, and you should consult with your physician regarding your specific medical condition and treatment options. This test is most effective when combined with clinical evaluation and other diagnostic findings.